Accurate and rapid diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been instrumental in mitigating viral spread during the coronavirus disease 2019 (COVID-19) ...

JOYSBIO, one of the world's leading manufacturers of COVID-19 tests, announces their tests are available everywhere and identifies new, dangerous variants. TIANJIN, China, Nov. 30, 2021 /PRNewswire/ - ...

Deependra Kumar Ban, Tyler Bodily, Abhijith G. Karkisaval, Yongliang Dong, Shreyam Natani, Anirudh Ramanathan, Armando Ramil, Sunil Srivastava, Prab Bandaru, Gennadi Glinsky, Ratnesh Lal Proceedings ...

The granting of emergency use authorization by the U.S. FDA to Roche AG for its four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and respiratory syncytial virus will allow the company ...

In a recent study posted to the bioRxiv* preprint server, researchers developed a novel in vitro model that expresses the angiotensin-converting enzyme 2 (ACE-2) receptor from seven bar species in a ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The U.S. Food and Drug Administration has granted Cellex an emergency use authorization to market a ...

PCR processes are the diagnostic gold standard when it comes to identifying coronavirus infections. Unlike rapid antigen tests, they function even in the case of a low viral load and detect the ...

Increased risk of DENV-infection (primarily DENV3) was observed up to 300 days post-SARS-CoV-2 infection (predominantly ...

After a recent COVID-19 exposure, Dr. Christina Astley tested positive on an at-home test—but just barely. The line signifying a positive result was so faint that Astley, an endocrinologist at Boston ...

Background Immunogenicity to SARS-CoV-2 vaccination in patients with SLE varies by vaccine type and immune-modulating therapy. However, data in Southeast Asian populations, especially among Thai ...